| Summary of condensed balance sheet |
The
following is the condensed financial information of the Company on a parent company only basis.
Condensed
balance sheets
Summary
of condensed balance sheet
| | |
2025 | | |
2024 | |
| | |
As of March 31, | |
| | |
2025 | | |
2024 | |
| ASSETS | |
| | | |
| | |
| Current assets: | |
| | | |
| | |
| Cash and cash equivalents | |
$ | 207,511 | | |
$ | 231,694 | |
| Deferred expenses | |
| 52,500 | | |
| 49,125 | |
| Prepayment and other current assets | |
| — | | |
| 70,000 | |
| Amounts due from subsidiaries and VIE | |
| 3,701,752 | | |
| 3,791,734 | |
| Amounts due from related parties | |
| 93,686 | | |
| — | |
| Investment in subsidiaries and VIE | |
| 10,595,038 | | |
| 17,358,111 | |
| TOTAL ASSETS | |
$ | 14,650,487 | | |
$ | 21,500,664 | |
| LIABILITIES | |
| | | |
| | |
| Current liabilities: | |
| | | |
| | |
| Amounts due to related parties | |
| 7,107 | | |
| 2,107 | |
| Amounts due to subsidiaries and VIE | |
| — | | |
| — | |
| Other payables | |
| — | | |
| — | |
| Accrued expenses and liabilities | |
| 297,405 | | |
| — | |
| Bond payable-current | |
| 600,000 | | |
| — | |
| TOTAL LIABILITIES | |
$ | 904,512 | | |
$ | 2,107 | |
| | |
| | | |
| | |
| SHAREHOLDERS’ EQUITY: | |
| | | |
| | |
| Ordinary shares, par value $0.0002 per share, 500,000,000 shares authorized; 15,929,451 and 15,449,451 shares issued and outstanding as of March 31, 2025 and 2024, respectively | |
| 3,186 | | |
| 3,090 | |
| Additional paid-in capital | |
| 17,872,227 | | |
| 19,055,297 | |
| Statutory reserve | |
| 40,590 | | |
| 745,590 | |
| (Accumulated Deficit)/Retained earnings | |
| (4,232,288 | ) | |
| 3,389,754 | |
| Accumulated other comprehensive income/(loss) | |
| 62,260 | | |
| (1,695,174 | ) |
| TOTAL SHAREHOLDERS’ EQUITY | |
$ | 13,745,975 | | |
$ | 21,498,557 | |
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | |
$ | 14,650,487 | | |
$ | 21,500,664 | |
|
| Summary of condensed statements of income |
Condensed
statements of income
Summary of condensed
statements of income
| | |
2025 | | |
2024 | | |
2023 | |
| | |
For the years ended March 31, | |
| | |
2025 | | |
2024 | | |
2023 | |
| General and administrative expenses | |
$ | (1,413,467 | ) | |
$ | (825,582 | ) | |
$ | (2,226,956 | ) |
| Investment loss, net | |
| — | | |
| — | | |
| — | |
| Share of profit in subsidiaries and VIE | |
| (6,155,143 | ) | |
| (4,629,554 | ) | |
| (18,678,368 | ) |
| Others, net | |
| (12,842 | ) | |
| 732,990 | | |
| (1,661 | ) |
| Provision for income tax | |
| — | | |
| — | | |
| — | |
| Net loss | |
$ | (7,581,452 | ) | |
$ | (4,722,146 | ) | |
$ | (20,906,985 | ) |
|
| Summary of condensed cash flow |
Condensed
cash flow
Summary of condensed
cash flow
| | |
2025 | | |
2024 | | |
2023 | |
| | |
For the year ended March 31, | |
| | |
2025 | | |
2024 | | |
2023 | |
| Net cash used in operating activities | |
$ | (624,183 | ) | |
$ | (966,510 | ) | |
$ | (1,779,420 | ) |
| Net cash used in investing activities | |
| — | | |
| — | | |
| (645,000 | ) |
| Net cash provided by financing activities | |
| 600,000 | | |
| — | | |
| 1,000,000 | |
| Net increase/(decrease) in cash and cash equivalent | |
$ | (24,183 | ) | |
$ | (966,510 | ) | |
$ | (1,424,420 | ) |
|
| Summary of condensed statements of comprehensive income |
Condensed
statements of comprehensive income
Summary of condensed
statements of comprehensive income
| | |
2025 | | |
2024 | | |
2023 | |
| | |
For the years ended March 31, | |
| | |
2025 | | |
2024 | | |
2023 | |
| Net loss | |
$ | (7,581,452 | ) | |
$ | (4,722,146 | ) | |
$ | (20,906,985 | ) |
| Other comprehensive income | |
| 107,698 | | |
| (733,539 | ) | |
| (3,402,058 | ) |
| Comprehensive income | |
$ | (7,473,754 | ) | |
$ | (5,455,685 | ) | |
$ | (24,309,043 | ) |
|